FDA Scientists Debate Results Of Glaxo Avandia Study
13th Jul 2010 20:14
By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES WASHINGTON (Dow Jones)--FDA scientists debated how to interpret the outcome of a large clinical trial that GlaxoSmithKline PLC (GSK) says backs the safety of its diabetes drug Avandia. Avandia is currently being reviewed by a federal pane
Read moreUPDATE: Calif. Supreme Court Clears Price-Fixing Suit Vs. Drug Makers
13th Jul 2010 17:54
(Adds details from court ruling beginning in fifth paragraph; comments for attorneys from both sides and company comments beginning in seventh paragraph) By Peter Loftus Of DOW JONES NEWSWIRES The California Supreme Court has reinstated a lawsuit in which retail pharmacies accused Pfizer
Read moreGlaxo Settles Avandia Lawsuits For $460 Mln -Bloomberg
13th Jul 2010 17:05
DOW JONES NEWSWIRES GlaxoSmithKline PLC (GSK, GSK.LN) has agreed to pay $460 million to settle most of the lawsuits connected to its Avandia diabetes drug, Bloomberg News reported Tuesday on its website, citing people familiar with the case. The settlements cover about 10,000 of the lawsui
Read moreMARKET TALK: Avandia Panel Ripples Through Blogosphere
13th Jul 2010 16:26
11:26 (Dow Jones) Today's FDA advisory committee meeting to evaluate safety of GlaxoSmithKline's (GSK) diabetes drug Avandia is generating lots of buzz on Twitter and various health blogs. For a sample, try CardioBrief.org by longtime medical journalist Larry Husten, who's posting updates with a tou
Read moreCalif Supreme Court Clears Price-Fixing Suit Vs. Drug Makers
13th Jul 2010 15:27
By Peter Loftus Of DOW JONES NEWSWIRES The California Supreme Court handed a legal victory to retail pharmacies that accused Pfizer Inc. (PFE) and other major drug makers of conspiring to set prices at artificially high levels. The pharmacies' lawsuit alleges drug makers acted in concer
Read moreN AMERICAN MORNING BRIEFING: Renewed Optimism To Lift Stocks
13th Jul 2010 11:40
DJIA Futures 10230.0 +51.0 +0.5% S&P 500 Futures 1083.2 +6.6 +0.6% Nasdaq Futures 1833.9 +13.6 +0.8% Above are as of 0615 ET FTSE 100 5241.5 +74.4 +1.4% Xetra DAX 6156.8 +79.7 +1.3% CAC40 3617.6 +50.0 +1.4% Above are as of 0
Read moreTuesday newspaper round-up: Banks, BP, GlaxoSmithKline
13th Jul 2010 06:35
The Government is considering introducing taxes on banks' pay and profits ? on top of the £2bn funding levy announced in the Budget. Mark Hoban, Financial Secretary to the Treasury, revealed the plan at a dinner for the country's most senior bankers at the Mansion House last night. He said that ba
Read moreUS HOT STOCKS: DineEquity, Qualcomm, Sprint Nextel, YRC -2-
12th Jul 2010 18:13
Shares of DineEquity Inc. (DIN, $31.03, +$2.16, +7.49%), parent of IHOP and Applebee's, gained following a mention in this week's issue of Barron's. The article noted that shares of the company have been hammered, but if its chief executive's strategy works out, investors could be richly rewarded. I
Read moreUS HOT STOCKS: Cliffs Natural, DineEquity, Protalix -2-
12th Jul 2010 15:39
After rallying Friday, material stocks gave back some of their gains. Decliners included Cliffs Natural Resources Inc. (CLF, $48.50, -$2.57, -5.03%), Freeport-McMoRan Copper & Gold Inc. (FCX, $63.96, -$2.02, -3.06%), U.S. Steel Corp. (X, $41.31, -$1.57, -3.66%) and AK Steel Holding Corp. (AKS, $12.7
Read moreMARKET TALK: Documents On Vivus Panel Coming Tuesday -FDA
12th Jul 2010 14:41
9:41 (Dow Jones) Briefing documents for Thursday's FDA panel on Vivus' (VVUS) Qnexa obesity drug won't be released until tomorrow, according to the agency. There was hope documents would be out prior to two-day hearing on GSK's Avandia beginning Tuesday. The documents should provide insights into so
Read moreUS EQUITIES WEEK AHEAD: 2Q Reports Begin; Inflation Data Due
9th Jul 2010 18:54
By Kathy Shwiff Of DOW JONES NEWSWIRES NEW YORK (Dow Jones)--The second-quarter earnings season begins Monday with a report by Alcoa Inc. (AA), the first blue-chip company to detail results through June. Little to no signs of inflation are expected when the U.S. government issues its Jun
Read moreUPDATE: FDA Staff Raise Concerns About Avandia Safety, Glaxo Study
9th Jul 2010 18:12
(Updates with additional comments and background.) By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES WASHINGTON (Dow Jones)--Food and Drug Administration staff scientists continued to question the safety of GlaxoSmithKline PLC's (GSK) diabetes drug Avandia, according to new agency docume
Read moreLondon close: Footsie rises again after strong week
9th Jul 2010 17:07
Footsie finished a very good week on the up again, helped by gains for the miners, life groups and Smith & Nephew. Antofagasta was the stand-out stock in the mining sector after Goldman Sachs issued a "buy" recommendation. Goldman Sach also advocates buying Anglo American ahead of an expected adv
Read moreFDA Staff Sees Risk With Avandia While Managers Are Divided>GSK
9th Jul 2010 15:11
By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES WASHINGTON (Dow Jones)--Food and Drug Administration staff scientists continued to question the safety of GlaxoSmithKline's (GSK) diabetes drug Avandia, according to new agency documents released Friday. The documents were prepared for a
Read moreLondon afternoon: Footsie condolidates gains
9th Jul 2010 14:39
Shares edged a little bit higher over the lunch time session with little sign yet of investors looking to bank the week's gains. Mining stocks are leading the advance. Antofagasta is the stand-out stock in the sector after Goldman Sachs issued a "buy" recommendation. Goldman Sach also advocates buy
Read more